The long-awaited rotation to value stocks may finally be coming, according to Evercore ISI.
A combination of smooth re-openings, improving infection rates, high retail-investor cash levels and the historically extreme relationship between growth and value stocks all support conditions for a risk-on rotation in the next couple of months, strategist Dennis DeBusschere wrote in a note Monday.
“Another round of fiscal support and a treatment/cure are critical for a persistent value rotation,” DeBusschere said. “The next two months could be the sweet spot for that trade as a fiscal stimulus is likely before the end of July and the huma- ingenuity trade (vaccine/cure development) remains positive” in Evercore ISI’s view, he wrote.
Value stocks have continued their long period of underperformance against growth peers amid the Covid-19 market uncertainty. The Russell 1000 Growth Index is up 2.5% year-to-date, while its value counterpart is off 20%. Without a macroeconomic turn, the case for value stocks remains weak, Bloomberg Intelligence Chief Equity Strategist Gina Martin Adamssaid May 15.
Quant Factors Are Swinging the Most Since 2009 in Stock Whiplash
If reopenings remain smooth, it reduces the chance that a second wave of Covid-19 will cause significant economic disruption — which in turn boosts the medium-term economic outlook and increases the attractiveness of equities, DeBusschere wrote. It would also reduce credit spreads, causing stocks with lower credit ratings to outperform near-term, he added.
“The P/E spread between the top quintile of historical growth and traditional value stocks is extreme,” DeBusschere wrote. “Investors need to be prepared for a violent move toward value if there is better-than-expected economic news or development of a vaccine.”
Source: Read Full Article